Xxera/openscience/retractions

Record #51845

High success rates for the use of sofosbuvir/ombitasvir/paritaprevir/ritonavir + ribavirin and sofosbuvir/simeprevir/daclatasvir + ribavirin in retreatment of chronic hepatitis C infection after unsuccessful sofosbuvir/daclatasvir therapy: a real-life experience

Ebada Mohamed Said, Badawy A Abdulaziz, Mohamed El Kassas, Ibrahim Hussein El Attar, Mohammed Emadeldeen, Sherief M Abd-Elsalam

Journal

Archives of Virology

Publisher

Original paper date

Apr 30, 2020

Original DOI

10.1007/s00705-020-04639-x

Country

Institution

Hepatology, Gastroenterology and Infectious Diseases Department, Faculty of Medicine, Benha University, Benha, Egypt · Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt · National Hepatology and Tropical Medicine Research Institute (NHTMRI), Cairo, Egypt · Tropical Medicine Department, Tanta University, Tanta, Egypt

Open access

No

Article type

Broad categories

(HSC) Medicine - Gastroenterology (HSC) Medicine - Infectious Disease (HSC) Medicine - Pharmacology

Citation lifecycle

How this paper is being cited

Pre-retraction

11

Same day

0

Post-retraction

1

% post-retraction

8.3%

~2.9 citations/yr before retraction · ~0.4 citations/yr after

— citing papers

Who is still citing this work

Loading…